Downstaging of Non-Small-Cell Lung Cancer Through Identification of Reversible Drug Toxicity

MeSH terms

• Adenocarcinoma / complications
• Adenocarcinoma / diagnosis*
• Adenocarcinoma / pathology
• Adenocarcinoma of Lung
• Anti-Infective Agents, Urinary / administration & dosage
• Anti-Infective Agents, Urinary / adverse effects*
• Carcinoma, Non-Small-Cell Lung / pathology
• Chronic Disease
• Cough / etiology
• Cryptogenic Organizing Pneumonia / diagnosis
• Cystitis / drug therapy*
• Diagnosis, Differential
• Dyspnea / etiology
• Fatigue / etiology
• Female
• Humans
• Lung / drug effects*
• Lung / pathology*
• Lung Diseases, Interstitial / chemically induced*
• Lung Diseases, Interstitial / complications
• Lung Diseases, Interstitial / diagnosis*
• Lung Diseases, Interstitial / pathology
• Lung Neoplasms / complications
• Lung Neoplasms / diagnosis*
• Lung Neoplasms / pathology
• Middle Aged
• Neoplasm Staging
• Nitrofurantoin / administration & dosage
• Nitrofurantoin / adverse effects*
• Positron-Emission Tomography
• Thoracic Surgery, Video-Assisted
• Tomography, X-Ray Computed
• Weight Loss